1. Home
  2. AHCO vs VIR Comparison

AHCO vs VIR Comparison

Compare AHCO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AdaptHealth Corp.

AHCO

AdaptHealth Corp.

HOLD

Current Price

$10.84

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.39

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHCO
VIR
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
AHCO
VIR
Price
$10.84
$9.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$13.50
$19.43
AVG Volume (30 Days)
1.4M
1.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
$3,244,857,000.00
$68,556,000.00
Revenue This Year
$9.00
$270.22
Revenue Next Year
$6.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.33
$4.16
52 Week High
$13.43
$11.66

Technical Indicators

Market Signals
Indicator
AHCO
VIR
Relative Strength Index (RSI) 33.66 44.42
Support Level $10.80 $8.47
Resistance Level $13.15 $10.29
Average True Range (ATR) 0.54 0.46
MACD -0.28 -0.16
Stochastic Oscillator 2.26 15.36

Price Performance

Historical Comparison
AHCO
VIR

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: